TOBRABACT 0.3 %, eye drop solution bottle, 5 ml
Active ingredients: Tobramycin
Commercialized according to BDPMDispensing in France: Prescription only
Eye drop solutionbottle, 5 mlophtalmique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TOBRABACT 0,3 %, collyre en solution
- Pharmaceutical form
- collyre en solution
- Route of administration
- ophtalmique
- Presentation description
- 1 flacon(s) polyéthylène basse densité (PEBD) de 5 ml muni d'un stilligoutte transparent polyéthylène basse densité
- Marketing authorisation holder
- MEDICOM HEALTHCARE IRELAND (IRLANDE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Jan 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69240211CIP73533406CIP133400935334060Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TOBRAMYCINEcollyre | 3 mg · 1 ml de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.